Coping with gastrointestinal and lung cancer without chemotherapy. Specialists at the Tel Aviv Sourasky Clinic (Ichilov) use an ultra-modern innovative method to combat neuroendocrine tumors. It is based on radionuclide therapy with the radioisotope Lutetium 177 (Lutetium-177). This innovation is a real breakthrough in oncotherapy, because in recent decades the number of cases of this type of cancer has been rapidly growing.
This method is completely new in the world. Today it exists only in Israel, Germany and Sweden.
Its essence is in the use of a new radiopharmaceutical - Lutetium 177 PRRT. The drug is administered intravenously at intervals of 7-8 weeks. With the help of Lutetium, cancer cells are destroyed selectively, without affecting healthy tissues of the body. That is, this method of treatment can literally be called "local radiation therapy". In addition, the drug does not have a toxic effect on the and kidneys, destroying the tumor from the inside.
In addition, the use of this method allows patients to avoid severe side effects of chemotherapy, such as vomiting, nausea, pain, alopecia, weakness. It is also important that the treatment is carried out by a special group of medical specialists. Among them: leading doctors, nurses and medical physicists!
All of them work under the supervision of Dr. Inna Ospovat, a leading specialist in the nuclear therapy department at the Ichilov Clinic.
Education
2000-1994 Faculty of Medicine in Vitebsk, Belarus.
Specialization
2003 - 2011 - specialization in oncology and radiation therapy at the Hadassah University Hospital in Jerusalem.
Recognized experience
Oncology and radiation therapy
Additional education
2015 - PMH University Hospital (Totonto) Childhood irradiation and head and neck tumors
Attending conferences
About 10 presentations at medical conferences
Trade union membership
Coping with gastrointestinal and lung cancer without chemotherapy. Specialists at the Tel Aviv Sourasky Clinic (Ichilov) use an ultra-modern innovative method to combat neuroendocrine tumors. It is based on radionuclide therapy with the radioisotope Lutetium 177 (Lutetium-177). This innovation is a real breakthrough in oncotherapy, because in recent decades the number of cases of this type of cancer has been rapidly growing.
This method is completely new in the world. Today it exists only in Israel, Germany and Sweden.
Its essence is in the use of a new radiopharmaceutical - Lutetium 177 PRRT. The drug is administered intravenously at intervals of 7-8 weeks. With the help of Lutetium, cancer cells are destroyed selectively, without affecting healthy tissues of the body. That is, this method of treatment can literally be called "local radiation therapy". In addition, the drug does not have a toxic effect on the and kidneys, destroying the tumor from the inside.
In addition, the use of this method allows patients to avoid severe side effects of chemotherapy, such as vomiting, nausea, pain, alopecia, weakness. It is also important that the treatment is carried out by a special group of medical specialists. Among them: leading doctors, nurses and medical physicists!
All of them work under the supervision of Dr. Inna Ospovat, a leading specialist in the nuclear therapy department at the Ichilov Clinic.
Education
2000-1994 Faculty of Medicine in Vitebsk, Belarus.
Specialization
2003 - 2011 - specialization in oncology and radiation therapy at the Hadassah University Hospital in Jerusalem.
Recognized experience
Oncology and radiation therapy
Additional education
2015 - PMH University Hospital (Totonto) Childhood irradiation and head and neck tumors
Attending conferences
About 10 presentations at medical conferences
Trade union membership
Education/Residency:
Dr. Tatyana Rabin's research interests include:
Methods of destruction of malignant neoplasms by heating with the help of ultrasonic waves, research into the use of brachytherapy in the treatment of oncogynecological diseases,
study of the mechanisms of response at the molecular level of prostate tumor cells to radiotherapy;
clinical studies of oncomammology, oncopulmonology, ocular lymphoma.
Dr. Rabin is investigating the molecular mechanisms by which prostate cancer cells respond to radiation therapy. This research is being conducted in collaboration with the Weizmann Institute of Science.
In addition, Dr. Rabin has been involved in clinical research in the areas of breast cancer, lung cancer, and ocular lymphoma.
Dr. Rabin is currently coordinating a new and unique study at Sheba Hospital that is investigating a method of treating cancerous tumors using MRI-guided ultrasound waves. This method involves raising the tumor's temperature to a certain level and then destroying it.
Awards:
Dr. Tatyana Rabin was recognized as the best hospital employee for 2007.
Experience and participation in scientific research:
Membership in medical societies :
Education/Residency:
Dr. Tatyana Rabin's research interests include:
Methods of destruction of malignant neoplasms by heating with the help of ultrasonic waves, research into the use of brachytherapy in the treatment of oncogynecological diseases,
study of the mechanisms of response at the molecular level of prostate tumor cells to radiotherapy;
clinical studies of oncomammology, oncopulmonology, ocular lymphoma.
Dr. Rabin is investigating the molecular mechanisms by which prostate cancer cells respond to radiation therapy. This research is being conducted in collaboration with the Weizmann Institute of Science.
In addition, Dr. Rabin has been involved in clinical research in the areas of breast cancer, lung cancer, and ocular lymphoma.
Dr. Rabin is currently coordinating a new and unique study at Sheba Hospital that is investigating a method of treating cancerous tumors using MRI-guided ultrasound waves. This method involves raising the tumor's temperature to a certain level and then destroying it.
Awards:
Dr. Tatyana Rabin was recognized as the best hospital employee for 2007.
Experience and participation in scientific research:
Membership in medical societies :
Education
Faculty of Medicine: Sackler Faculty of Medicine, Tel Aviv University
Specialization
Institute of Oncology, Davydov Center, Beilinson Hospital
Recognized experience
Medical Oncology and Radiation Therapy
Additional education
Department of Radiation Therapy, Duke University Medical Center, USA
Clinical experience
Attending conferences
About 15 professional publications
Trade union membership
Areas of special interest and activities
Cerebral metastases and primary brain tumors, head and neck tumors, radiation therapy and radiosurgery
Read moreEducation
Faculty of Medicine: Sackler Faculty of Medicine, Tel Aviv University
Specialization
Institute of Oncology, Davydov Center, Beilinson Hospital
Recognized experience
Medical Oncology and Radiation Therapy
Additional education
Department of Radiation Therapy, Duke University Medical Center, USA
Clinical experience
Attending conferences
About 15 professional publications
Trade union membership
Areas of special interest and activities
Cerebral metastases and primary brain tumors, head and neck tumors, radiation therapy and radiosurgery
Professor Shlomi Constantini is a highly-trained neurosurgeon in Israel with expertise in general and pediatric neurosurgery, microsurgical operations, reconstructive interventions, and brain and spine tumor treatments. He has received several awards and is a member of multiple professional organizations.
Read moreProfessor Shlomi Constantini is a highly-trained neurosurgeon in Israel with expertise in general and pediatric neurosurgery, microsurgical operations, reconstructive interventions, and brain and spine tumor treatments. He has received several awards and is a member of multiple professional organizations.
Dr. Avi Hefetz is Head of the department of surgery and head and neck oncology at the medical center head and neck surgery at Melanoma Unit department of the largest Israel hospital - Assuta. Leading specialist in the diagnosis and surgical treatment of tumors in the head and neck, as well as, where appropriate, non-surgical treatment of the disease.
Clinical practice of doctor Hefetz combined with teaching and research activities, he teaches at Tel Aviv University, is the author of over 70 scientific articles which are published in various professional journals, has spent more than 40 scientific presentations.
Dr. Avi Hefetz is Head of the department of surgery and head and neck oncology at the medical center head and neck surgery at Melanoma Unit department of the largest Israel hospital - Assuta. Leading specialist in the diagnosis and surgical treatment of tumors in the head and neck, as well as, where appropriate, non-surgical treatment of the disease.
Clinical practice of doctor Hefetz combined with teaching and research activities, he teaches at Tel Aviv University, is the author of over 70 scientific articles which are published in various professional journals, has spent more than 40 scientific presentations.
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Chief Physician of the Oncology Center, Oncologist
Read moreChief Physician of the Oncology Center, Oncologist
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Surgeon, Specialist in Laparoscopic and Colorectal Surgery
Read moreSurgeon, Specialist in Laparoscopic and Colorectal Surgery
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Urologist, Specialist in Oncourology
Read moreUrologist, Specialist in Oncourology
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Prof. Moshe Inbar is an Israeli oncologist and the Head of Department of Oncology at Sourasky (Ichilov) Medical Center, specializing in breast cancer, cancer of the uterus and ovaries, urogenital cancer in female and male, and gastro-intestinal cancer. He is a Clinical Associate Professor in Tel Aviv University, holds numerous awards and is a member of various research organizations.
Read moreProf. Moshe Inbar is an Israeli oncologist and the Head of Department of Oncology at Sourasky (Ichilov) Medical Center, specializing in breast cancer, cancer of the uterus and ovaries, urogenital cancer in female and male, and gastro-intestinal cancer. He is a Clinical Associate Professor in Tel Aviv University, holds numerous awards and is a member of various research organizations.
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Dr. Riad Hadad is a leading Israeli surgeon and oncologist. He specializes in surgical treatment of gastrointestinal and liver cancer.
Dr. Riad Hadad is the author of 60 scientific publications and a speaker at international symposia and conferences.
Dr. Riad Hadad is a leading Israeli surgeon and oncologist. He specializes in surgical treatment of gastrointestinal and liver cancer.
Dr. Riad Hadad is the author of 60 scientific publications and a speaker at international symposia and conferences.
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Specialist in bariatric surgery
Read moreSpecialist in bariatric surgery
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Otolaryngologist
Read moreOtolaryngologist
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Orthopedist, Specialist in endoprosthetics
Read moreOrthopedist, Specialist in endoprosthetics
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Oncologist, Radiologist
Read moreOncologist, Radiologist
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Oncologist, Radiologist
Read moreOncologist, Radiologist
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Head of the Breast Surgery Department, Mammologist
Read moreHead of the Breast Surgery Department, Mammologist
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |
Gynecologist, Specialist in endoscopic and laparoscopic operations
Read moreGynecologist, Specialist in endoscopic and laparoscopic operations
Doctor's visit | price on request |
Immunotherapy for prostate cancer | $2500 |
Radiotherapy for prostate cancer | $8800 |
Immunotherapy | $3800 - $5000 |